Cargando…
KLC1-ALK: A Novel Fusion in Lung Cancer Identified Using a Formalin-Fixed Paraffin-Embedded Tissue Only
The promising results of anaplastic lymphoma kinase (ALK) inhibitors have changed the significance of ALK fusions in several types of cancer. These fusions are no longer mere research targets or diagnostic markers, but they are now directly linked to the therapeutic benefit of patients. However, mos...
Autores principales: | Togashi, Yuki, Soda, Manabu, Sakata, Seiji, Sugawara, Emiko, Hatano, Satoko, Asaka, Reimi, Nakajima, Takashi, Mano, Hiroyuki, Takeuchi, Kengo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3275577/ https://www.ncbi.nlm.nih.gov/pubmed/22347464 http://dx.doi.org/10.1371/journal.pone.0031323 |
Ejemplares similares
-
Establishment of a novel protocol for formalin-fixed paraffin-embedded organoids and spheroids
por: Yoshimoto, Shohei, et al.
Publicado: (2023) -
Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFR mutation
por: Miyanaga, Akihiko, et al.
Publicado: (2013) -
Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in KLC1–ALK-rearranged lung cancer
por: Dietz, Steffen, et al.
Publicado: (2019) -
MicroSEC filters sequence errors for formalin-fixed and paraffin-embedded samples
por: Ikegami, Masachika, et al.
Publicado: (2021) -
Epithelioid cell histiocytoma with SQSTM1-ALK fusion: a case report
por: Nakayama, Ryuko, et al.
Publicado: (2018)